Chinese lozenges maker Golden Throat overcame testing market conditions on Tuesday to successfully price its initial public offering in Hong Kong, albeit near the bottom of its indicative range as Chinese share worries continued to swirl.
Beijing suspended new share sales over the weekend in a bid to stabilise the country’s stock markets, after these fell almost 30% in three weeks. Some 760 companies more than a quarter of all A-share listed-companies on the Shanghai and Shenzhen exchanges have also so far suspended share trading, according to media reports.
Golden Throat, a very well known cough sweet maker in China,...
¬ Haymarket Media Limited. All rights reserved.
